{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:19:54Z","timestamp":1791807594983,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jhepr.2023.100712","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T13:08:21Z","timestamp":1677244101000},"page":"100712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis"],"prefix":"10.1016","volume":"5","author":[{"given":"Benedikt","family":"Simbrunner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Jachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.M.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Scheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt Silvester","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Friedrich","family":"St\u00e4ttermayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrig","family":"Marculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100712_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3389\/fimmu.2019.00973","article-title":"Dysfunctional immune response in acute-on-chronic liver failure: it takes two to tango","volume":"10","author":"Martin-Mateos","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100712_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.14522","article-title":"Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity","volume":"47","author":"Mandorfer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100712_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100712_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100712_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and\u00a0should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100712_bib9","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.3748\/wjg.v25.i39.5897","article-title":"Gut-liver axis signaling in portal hypertension","volume":"25","author":"Simbrunner","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100712_bib10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100712_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gut.40.4.544","article-title":"Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality","volume":"40","author":"Homann","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100712_bib12","first-page":"1451","article-title":"Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis","volume":"51","author":"Baumann","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhepr.2023.100712_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2495073","article-title":"Serum immunoglobulin A (IgA) level is a potential biomarker indicating cirrhosis during chronic hepatitis B infection","volume":"2016","author":"Lin","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jhepr.2023.100712_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2893.2004.00507.x","article-title":"Serum\u00a0immunoglobulins predict the extent of hepatic fibrosis in patients\u00a0with chronic hepatitis C virus infection","volume":"11","author":"Watt","year":"2004","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100712_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib17","article-title":"Measurement of the hepatic venous pressure gradient and transjugular\u00a0liver biopsy","volume":"160","author":"Reiberger","year":"2020","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.jhepr.2023.100712_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s12072-020-10112-3","article-title":"Vitamin A levels reflect disease severity and\u00a0portal\u00a0hypertension in patients with cirrhosis","volume":"14","author":"Simbrunner","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100712_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/gutjnl-2020-320786","article-title":"Targeting the gut-liver-immune axis to treat cirrhosis","volume":"70","author":"Tranah","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100712_bib22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/apt.16602","article-title":"Therapeutic aspects of bile acid signalling in the gut-liver axis","volume":"54","author":"Simbrunner","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100712_bib23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2010.11.034","article-title":"Evidence of neutrophil functional defect despite inflammation in stable cirrhosis","volume":"55","author":"Tritto","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/hep.24689","article-title":"Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population","volume":"55","author":"Doi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100712_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ebiom.2019.10.011","article-title":"CD8(+)T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction","volume":"49","author":"Leboss\u00e9","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jhepr.2023.100712_bib26","first-page":"333","article-title":"The complement system in liver diseases","volume":"3","author":"Qin","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhepr.2023.100712_bib27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22034","article-title":"Liver: an organ with predominant innate immunity","volume":"47","author":"Gao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100712_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/00365521.2017.1386710","article-title":"Prognostic value of\u00a0lectin pathway molecules and complement proteins in ascitic fluid and\u00a0blood in patients with liver cirrhosis","volume":"53","author":"Glargaard","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100712_bib29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.1840120516","article-title":"Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis","volume":"12","author":"Such","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100712_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s10875-007-9090-2","article-title":"Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis","volume":"27","author":"Franc\u00e9s","year":"2007","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100712_bib31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.1840160309","article-title":"Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patients","volume":"16","author":"Gir\u00f3n","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100712_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0966-3274(02)00084-9","article-title":"Time-course changes of serum immunoglobulins (IgA, IgG, IgM) after liver transplantation for alcoholic cirrhosis","volume":"11","author":"Gonz\u00e1lez-Quintela","year":"2003","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jhepr.2023.100712_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2249.2009.04004.x","article-title":"Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation","volume":"158","author":"Massonnet","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhepr.2023.100712_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11882-015-0580-7","article-title":"IgG4 characteristics and functions in cancer immunity","volume":"16","author":"Crescioli","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jhepr.2023.100712_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2249.2009.04005.x","article-title":"Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis","volume":"158","author":"M\u00e1rquez","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhepr.2023.100712_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2021.04.022","article-title":"Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis","volume":"75","author":"Villanueva","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100712_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/1389203720666190405101138","article-title":"The immune functions of \u03b1(1) acid glycoprotein","volume":"20","author":"Ceciliani","year":"2019","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.jhepr.2023.100712_bib40","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41590-020-0698-1","article-title":"Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity","volume":"21","author":"Smole","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhepr.2023.100712_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803244","article-title":"Alpha-2-macroglobulin in inflammation, immunity and infections","volume":"12","author":"Vandooren","year":"2021","journal-title":"Front Immunol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:30:36Z","timestamp":1762900236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923000435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2589555923000435"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100712","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100712"}}